The global lopinavir/ritonavir market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The combination of lopinavir and ritonavir is used with other drugs to treat human immunodeficiency HIV infection and other types of cancer. The rising prevalence of the HIV along with the development of advanced treatment options is a […]
